tradingkey.logo

Elicio Therapeutics Inc

ELTX
8.100USD
+0.160+2.02%
Market hours ETQuotes delayed by 15 min
139.80MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Elicio Therapeutics Inc here for insights into the performance and operational efficiency of Elicio Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q2
FY2019Q4
Total revenue
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
-100.00%0.00
20.93%653.00K
344.20%1.65M
5551.63%25.94M
--1.46M
-25.93%540.00K
--371.00K
-34.05%459.00K
--729.00K
--696.00K
Revenue
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
20.93%653.00K
344.20%1.65M
5551.63%25.94M
--1.46M
-25.93%540.00K
--371.00K
-34.05%459.00K
--729.00K
--696.00K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
246.40%433.00K
--0.00
-100.00%0.00
--0.00
-58.19%125.00K
--333.00K
--299.00K
Operating expenses
-22.23%8.04M
-7.63%10.09M
4.83%10.74M
43.48%13.48M
-3.96%10.34M
40.47%10.92M
31.21%10.24M
140.51%9.39M
72.25%10.77M
-19.73%7.78M
-51.62%7.80M
-65.46%3.91M
-63.68%6.25M
-48.42%9.69M
-20.57%16.13M
-20.98%11.31M
--17.22M
4.37%18.78M
--20.31M
-3.90%14.31M
--18.00M
--14.89M
R&D expenses
-30.09%5.04M
-14.35%7.01M
2.90%7.78M
73.93%10.71M
-0.77%7.21M
65.45%8.18M
37.84%7.56M
3748.13%6.16M
147.24%7.26M
-18.59%4.94M
-53.00%5.48M
-97.60%160.00K
-77.89%2.94M
-57.95%6.07M
-18.40%11.67M
-39.74%6.67M
--13.29M
18.10%14.44M
--14.30M
5.92%11.06M
--12.23M
--10.45M
Depreciation, depletion, and amortization
-65.52%100.00K
-65.87%100.00K
-4.14%278.00K
6.64%305.00K
6.23%290.00K
-47.96%293.00K
163.64%290.00K
18.67%286.00K
-5.86%273.00K
142.67%563.00K
-51.75%110.00K
8.07%241.00K
33.64%290.00K
12.62%232.00K
47.10%228.00K
52.74%223.00K
--217.00K
338.30%206.00K
--155.00K
711.11%146.00K
--47.00K
--18.00K
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.00K
----
----
Operating profit
22.23%-8.04M
7.63%-10.09M
-4.83%-10.74M
-43.48%-13.48M
3.96%-10.34M
-40.47%-10.92M
-31.21%-10.24M
-140.51%-9.39M
-72.25%-10.77M
13.92%-7.78M
46.12%-7.80M
-126.68%-3.91M
60.32%-6.25M
50.48%-9.04M
27.35%-14.48M
205.66%14.63M
---15.76M
-5.65%-18.24M
---19.94M
2.42%-13.85M
---17.27M
---14.19M
Net non-operating interest income (expenses)
Non-operating interest income
7.57%199.00K
22.63%168.00K
40.00%210.00K
306.67%305.00K
-24.80%185.00K
251.28%137.00K
1400.00%150.00K
--75.00K
--246.00K
--39.00K
--10.00K
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
210.95%426.00K
295.92%194.00K
388.89%176.00K
11600.00%234.00K
13600.00%137.00K
-93.14%49.00K
-89.47%36.00K
--2.00K
--1.00K
--714.00K
--342.00K
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
100.00%0.00
100.00%0.00
-100.00%0.00
-96.79%8.00K
96.97%-1.00K
0.00%-9.00K
--153.00K
22.06%249.00K
84.65%-33.00K
97.33%-9.00K
-100.00%0.00
500.00%204.00K
-5.39%-215.00K
-1431.82%-337.00K
309.43%111.00K
-89.51%34.00K
---204.00K
90.79%-22.00K
---53.00K
--324.00K
---239.00K
----
Return on equity
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
-55.00%9.00K
480.00%133.00K
-83.64%9.00K
-9.45%-139.00K
--20.00K
-225.00%-35.00K
--55.00K
-326.79%-127.00K
--28.00K
--56.00K
Special income (expenses)
67.76%-1.81M
-123.76%-859.00K
60.33%-507.00K
-3893.75%-607.00K
-93716.67%-5.62M
300.89%3.62M
-1283.33%-1.28M
100.51%16.00K
100.22%6.00K
2047.62%902.00K
176.92%108.00K
-1254.78%-3.14M
-2278.13%-2.79M
-96.20%42.00K
100.35%39.00K
102.93%272.00K
--128.00K
146.55%1.10M
---10.99M
-390.29%-9.29M
---2.37M
---1.90M
- Gains from disposal of fixed assets
--0.00
--0.00
-100.00%0.00
-100.00%0.00
100.00%0.00
--0.00
--3.00K
--105.00K
---105.00K
----
--0.00
----
----
----
----
100.00%0.00
----
----
----
---58.00K
----
----
Other non-operating income (expenses)
100.00%0.00
--415.00K
100.00%0.00
--0.00
---2.92M
--0.00
---578.00K
----
----
----
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
--0.00
---3.59M
---274.00K
----
----
Income before tax
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
---36.69M
-80.30%-28.88M
---20.34M
---16.02M
Income tax
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
---36.69M
-80.30%-28.88M
---20.34M
---16.02M
Net income from continuous operations
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
---36.69M
-80.30%-28.88M
---20.34M
---16.02M
Net income attributable to controlling interests
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
---36.69M
-80.30%-28.88M
---20.34M
---16.02M
Net income attributable to common shareholders
46.48%-10.08M
-46.09%-10.56M
5.23%-11.21M
-56.49%-14.00M
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-38.96%-8.95M
-18.58%-10.66M
17.29%-7.56M
43.62%-8.03M
-143.25%-6.44M
42.77%-8.99M
46.47%-9.14M
61.19%-14.24M
151.57%14.89M
---15.70M
16.07%-17.07M
---36.69M
-80.30%-28.88M
---20.34M
---16.02M
Basic earnings per share
56.45%-0.60
-2.66%-0.66
24.81%-0.87
42.04%-1.03
-9.00%-1.39
73.72%-0.64
56.82%-1.15
17.24%-1.77
57.37%-1.27
20.05%-2.44
43.91%-2.67
-143.04%-2.14
43.31%-2.98
47.01%-3.05
69.63%-4.75
125.40%4.97
---5.26
58.94%-5.75
---15.65
-21.85%-19.56
---14.01
---16.05
Diluted earnings per share
56.45%-0.60
-2.66%-0.66
24.81%-0.87
42.04%-1.03
-9.00%-1.39
73.72%-0.64
56.82%-1.15
17.24%-1.77
57.37%-1.27
20.05%-2.44
43.91%-2.67
-143.04%-2.14
43.31%-2.98
47.01%-3.05
69.63%-4.75
125.40%4.97
---5.26
58.94%-5.75
---15.65
-21.85%-19.56
---14.01
---16.05
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI